M Pharmaceutical Inc. announced that it has entered into a manufacturing supply agreement with Rishena Co., Ltd., to manufacture the company's Trimtec gastric functional neurostimulation device. Under the terms of the agreement, Rishena will be the exclusive supplier of laparoscopically-implantable Trimtec devices to M Pharmaceutical for the North and South American markets. The devices will be fully programmable and rechargeable through an abdominal belt.